Genmab Announces Financial Results for the First Quarter of 2024May 8, 2025 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2025HighlightsEPKINLY® (epcoritamab) approved by ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus” or the "Company”), today announced that Yuval Cohen, Ph.D., ...

During the second half of 2025, Werewolf plans to present interim data from the monotherapy and combination expansion arms, including tolerability, response rate, and durability, and to engage with ...

AMH (NYSE: AMH) (the "Company"), a leading large-scale integrated owner, operator and developer of single-family rental homes, today announced that the Board of Trustees declared a dividend of $0.30 ...

THE Securities and Exchange Commission (SEC) on Tuesday launched six digital platforms and an in-house data center aimed at ...

Securities and Exchange Commission (SEC) chairperson Emilio Aquino is hopeful that his successor will continue the digital ...

The Securities and Exchange Commission (SEC) said Tuesday it launched six new digital platforms and a modern data center as ...

The Company reported a net loss of approximately $17.0 million, or a net loss per basic and diluted share of $1.39, for the ...

SEC Davao reminds corporations to comply with the 2025 deadlines for online submission of Annual Financial Statements (AFS) ...